Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: A meta-analysis

References

• World Health Organization, Strategic Advisory Group of Experts (SAGE) Working Group. Background paper on influenza vaccines and immunization. 2012. Available at: http://www.who.int/entity/immunization/sage/meetings/2012/april/1_Background_Paper_Mar26_v13_cleaned.pdf?ua=1. Accessed: January 5, 2016.
   Google Scholar
• Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005; 366:1165-74; PMID:16198765; http://dx.doi.org/10.1016/S0140-6736(05)67339-4
   PubMed Web of Science ®Google Scholar
• Darvishian M, Gefenaite G, Turner RM, Pechlivanoglou P, Van der Hoek W, Van den Heuvel ER, Hak E. After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly. J Clin Epidemiol 2014; 67:734-44; PMID:24768004; http://dx.doi.org/10.1016/j.jclinepi.2014.02.009
   PubMed Web of Science ®Google Scholar
• Palacios G, Hornig M, Cisterna D, Savji N, Bussetti AV, Kapoor V, Hui J, Tokarz R, Briese T, Baumeister E, et al. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS One 2009; 4:e8540; PMID:20046873; http://dx.doi.org/10.1371/journal.pone.0008540
   PubMed Web of Science ®Google Scholar
• Walter ND, Taylor TH, Shay DK, Thompson WW, Brammer L, Dowell SF, Moore MR, Active Bacterial Core Surveillance Team. Influenza circulation and the burden of invasive pneumococcal pneumonia during a non-pandemic period in the United States. Clin Infect Dis 2010; 50:175-83; PMID:20014948; http://dx.doi.org/10.1086/649208
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Wkly Rep 2010; 59:1102-6; PMID:20814406
   PubMedGoogle Scholar
• Ochoa-Gondar O, Vila-Corcoles A, Rodriguez-Blanco T, Gomez-Bertomeu F, Figuerola-Massana E, Raga-Luria X, Hospital-Guardiola I. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study. Clin Infect Dis 2014; 58:909-17; PMID:24532544; http://dx.doi.org/10.1093/cid/ciu002
   PubMed Web of Science ®Google Scholar
• Ogilvie I, Khoury AE, Cui Y, Dasbach E, Grabenstein JD, Goetghebeur M. Cost-effectiveness of pneumococcal polysaccharide vaccination in adults: a systematic review of conclusions and assumptions. Vaccine 2009; 27:4891-904; PMID:19520205; http://dx.doi.org/10.1016/j.vaccine.2009.05.061
   PubMed Web of Science ®Google Scholar
• Smith KJ, Wateska AR, Nowalk MP, Raymund M, Lee BY, Zimmerman RK. Modeling of cost effectiveness of pneumococcal conjugate vaccination strategies in U.S. older adults. Am J Prev Med 2013; 44:373-81; PMID:23498103; http://dx.doi.org/10.1016/j.amepre.2012.11.035
   PubMed Web of Science ®Google Scholar
• Isturiz R, Webber C. Prevention of adult pneumococcal pneumonia with the 13-valent pneumococcal conjugate vaccine: CAPiTA, the community-acquired pneumonia immunization trial in adults. Hum Vaccin Immunother 2015; 11:1825-7; PMID:26076136; http://dx.doi.org/10.1080/21645515.2015.1043502
   PubMed Web of Science ®Google Scholar
• Bonten MJ, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Gault S, van Werkhoven CH, van Deursen AM, Sanders EA, Verheij TJ, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med 2015; 372:1114-25; PMID:25785969; http://dx.doi.org/10.1056/NEJMoa1408544
   PubMed Web of Science ®Google Scholar
• Tomczyk S, Bennett NM, Stoecker C, Gierke R, Moore MR, Whitney CG, Hadler S, Pilishvili T, Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥ 65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). MWR Morb Mortal Wkly Rep 2014; 63:822-5
   Google Scholar
• Fedson DS, Liss C. Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults. Vaccine 2004; 22:927-46; PMID:15161070; http://dx.doi.org/10.1016/j.vaccine.2003.09.027
   PubMed Web of Science ®Google Scholar
• Hollingsworth R, Isturiz R. Pneumococcal vaccination of older adults: conjugate or polysaccharide? Hum Vaccin Immunother 2014; 10:45-6; PMID:24018552; http://dx.doi.org/10.4161/hv.26330
   PubMed Web of Science ®Google Scholar
• Li C, Gubbins PO, Chen GJ. Prior pneumococcal and influenza vaccinations and in-hospital outcomes for community-acquired pneumonia in elderly veterans. J Hosp Med 2015; 10:287-93; PMID:25676363; http://dx.doi.org/10.1002/jhm.2328
   PubMed Web of Science ®Google Scholar
• Gilchrist SA, Nanni A, Levine O. Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers. Am J Public Health 2012; 102:596-605; PMID:22397339; http://dx.doi.org/10.2105/AJPH.2011.300512
   PubMed Web of Science ®Google Scholar
• Nichol KL. The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease. Vaccine 1999; 17:S91-3; PMID:10471189; http://dx.doi.org/10.1016/S0264-410X(99)00114-0
   PubMed Web of Science ®Google Scholar
• Christenson B, Pauksen K, Sylvan SP. Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity. Virol J 2008; 5:52; PMID:18442371; http://dx.doi.org/10.1186/1743-422X-5-52
   PubMed Web of Science ®Google Scholar
• Grilli G, Fuiano L, Biasio LR, Pregliasco F, Plebani A, Leibovitz M, Ugazio AG, Vacca F, Profeta ML. Simultaneous influenza and pneumococcal vaccination in elderly individuals. Eur J Epidemiol 1997; 13:287-91; PMID:9258527; http://dx.doi.org/10.1023/A:1007398606807
   PubMed Web of Science ®Google Scholar
• Domínguez A, Castilla J, Godoy P, Delgado-Rodríguez M, Saez M, Soldevila N, Astray J, Mayoral JM, Martín V, Quintana JM, et al. Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009–2010 and 2010–2011 seasons. Hum Vaccin Immunother 2013; 9:865-73; http://dx.doi.org/10.4161/hv.23090
   PubMed Web of Science ®Google Scholar
• Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, de Diego-Cabanes C, Satue-Gracia E, Vila-Rovira A, Torrente Fraga C, EPIVAC Research Group. Evaluating clinical effectiveness of pneumococcal vaccination in preventing stroke: the CAPAMIS Study, 3-year follow-up. J Stroke Cerebrovasc Dis 2014; 23:1577-84; PMID:24656243; http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2013.12.047
   PubMed Web of Science ®Google Scholar
• Assendelf WJ, Scholten RJ, Offringa M. Pneumococcal vaccination for the elderly in The Netherlands? Assessment of the quality and content of available comparative studies. Neth J Med 2004; 62:36-44; PMID:15127829
   PubMed Web of Science ®Google Scholar
• Honkanen PO, Keistinen T, Miettinen L, Herva E, Sankilampi U, Läärä E, Leinonen M, Kivelä SL, Mäkelä PH. Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older. Vaccine 1999; 17:2493-500; PMID:10418894; http://dx.doi.org/10.1016/S0264-410X(99)00069-9
   PubMed Web of Science ®Google Scholar
• Furumoto A, Ohkusa Y, Chen M, Kawakami K, Masaki H, Sueyasu Y, Iwanaga T, Aizawa H, Nagatake T, Oishi K. Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease. Vaccine 2008; 26:4284-9; PMID:18585831; http://dx.doi.org/10.1016/j.vaccine.2008.05.037
   PubMed Web of Science ®Google Scholar
• Chan TC, Hung IF, Luk JK, Shea YF, Chan FH, Woo PC, Chu LW. Prevention of mortality and pneumonia among nursing home older adults by dual pneumococcal and seasonal influenza vaccination during a pandemic caused by novel pandemic influenza A (H1N1). J Am Med Dir Assoc 2012; 13:698-703; PMID:22722051; http://dx.doi.org/10.1016/j.jamda.2012.05.009
   PubMed Web of Science ®Google Scholar
• Chang YC, Chou YJ, Liu JY, Yeh TF, Huang N. Additive benefits of pneumococcal and influenza vaccines among elderly persons aged 75 years or older in Taiwan–a representative population-based comparative study. J Infect 2012; 65:231-8; PMID:22561486; http://dx.doi.org/10.1016/j.jinf.2012.04.014
   PubMed Web of Science ®Google Scholar
• Kawakami K, Ohkusa Y, Kuroki R, Tanaka T, Koyama K, Harada Y, Iwanaga K, Yamaryo T, Oishi K. Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan. Vaccine 2010; 28:7063-9; PMID:20723631; http://dx.doi.org/10.1016/j.vaccine.2010.08.010
   PubMed Web of Science ®Google Scholar
• Christenson B, Hedlund J, Lundbergh P, Ortqvist A. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J 2004; 23:363-8; PMID:15065822; http://dx.doi.org/10.1183/09031936.04.00063504
   PubMed Web of Science ®Google Scholar
• Hung IF, Leung AY, Chu DW, Leung D, Cheung T, Chan CK, Lam CL, Liu SH, Chu CM, Ho PL, et al. Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcaland influenza vaccination: a prospective cohort study. Clin Infect Dis 2010; 51:1007-16; PMID:20887208; http://dx.doi.org/10.1086/656587
   PubMed Web of Science ®Google Scholar
• Wells G, Shea B, O'Connell J, Robertson J, Peterson V, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analysis. Available at: http://www.ohri.ca/programs/clinical_epidemiology/nos_manual.pdf
   Google Scholar
• Frenck RW Jr, Gurtman A, Rubino J, Smith W, van Cleeff M, Jayawardene D, Giardina PC, Emini EA, Gruber WC, Scott DA, et al. Randomized, controlled trial of a 13-valent pneumococcal conjugate vaccine administered concomitantly with an influenza vaccine in healthy adults. Clin Vaccine Immunol 2012; 19:1296-303; PMID:22739693; http://dx.doi.org/10.1128/CVI.00176-12
   PubMed Web of Science ®Google Scholar
• Socan M, Frelih T, Janet E, Petras T, Peternelj B. Reactions after pneumococcal vaccine alone or in combination with influenza vaccine. Vaccine 2004; 22:3087-91; PMID:15297059; http://dx.doi.org/10.1016/j.vaccine.2004.02.003
   PubMed Web of Science ®Google Scholar
• Shiramoto M, Hanada R, Juergens C, Shoji Y, Yoshida M, Ballan B, Cooper D, Gruber WC, Scott DA, Schmoele-Thoma B. Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults. Hum Vaccin Immunother 2015; 11:2198-206; PMID:26176163; http://dx.doi.org/10.1080/21645515.2015.1030550
   PubMed Web of Science ®Google Scholar
• Jackson LA, Gurtman A, van Cleeff M, Jansen KU, Jayawardene D, Devlin C, Scott DA, Emini EA, Gruber WC, Schmoele-Thoma B. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults. Vaccine 2013; 31:3577-84; PMID:23688526; http://dx.doi.org/10.1016/j.vaccine.2013.04.085
   PubMed Web of Science ®Google Scholar
• Cai L, Uchiyama H, Yanagisawa S, Kamae I. Cost-effectiveness analysis of influenza and pneumococcal vaccinations among elderly people in Japan. Kobe J Med Sci 2006; 52:97-109; PMID:16855372
   PubMedGoogle Scholar
• You JH, Wong WC, Ip M, Lee NL, Ho SC. Cost-effectiveness analysis of influenza and pneumococcal vaccination for Hong Kong elderly in long-term care facilities. J Epidemiol Community Health 2009; 63:906-11; PMID:19608558; http://dx.doi.org/10.1136/jech.2008.081885
   PubMed Web of Science ®Google Scholar
• Smith KJ, Wateska AR, Nowalk MP, Raymund M, Nuorti JP, Zimmerman RK. Cost-effectiveness of adult vaccination strategies using pneumococcal conjugate vaccine compared with pneumococcal polysaccharide vaccine. JAMA 2012; 307:804-12; PMID:22357831
   PubMed Web of Science ®Google Scholar
• Ament A, Baltussen R, Duru G, Rigaud-Bully C, de Graeve D, Ortqvist A, Jönsson B, Verhaegen J, Gaillat J, Christie P, et al. Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries. Clin Infect Dis 2000; 31:444-50; PMID:10987703; http://dx.doi.org/10.1086/313977
   PubMed Web of Science ®Google Scholar
• Fedson DS, Guppy MJ. Pneumococcal vaccination of older adults: conjugate or polysaccharide? Hum Vaccin Immunother 2013; 9:1382-4; PMID:23732892; http://dx.doi.org/10.4161/hv.24692
   PubMed Web of Science ®Google Scholar
• Evers SM, Ament AJ, Colombo GL, Konradsen HB, Reinert RR, Sauerland D, Wittrup-Jensen K, Loiseau C, Fedson DS. Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries. Eur J Clin Microbiol Infect Dis 2007; 26:531-40; PMID:17570001; http://dx.doi.org/10.1007/s10096-007-0327-z
   PubMed Web of Science ®Google Scholar
• Raboisson D, Mounié M, Maigné E. Diseases, reproductive performance, and changes in milk production associated with subclinical ketosis in dairy cows: a meta-analysis and review. J Dairy Sci 2014; 97:7547-63; PMID:25306269; http://dx.doi.org/10.3168/jds.2014-8237
   PubMed Web of Science ®Google Scholar
• Zheng Y, Lu C, Wei S, Li Y, Long L, Yin P. Association of red blood cell transfusion and in-hospital mortality in patients admitted to the intensive care unit: a systematic review and meta-analysis. Crit Care 2014; 18:515. doi: 10.1186/s13054-014-0515-z; PMID:25394759
   PubMed Web of Science ®Google Scholar
• Larsson SC, Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer 2007; 97:1005-8; PMID:17700568
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009; 151:W65-94; PMID:19622512; http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00136
   PubMed Web of Science ®Google Scholar
• Protocol for case-control studies of influenza vaccine effectiveness in the European Union and European Economic Area Member States. ECDC Technical Document. Available at: http://ecdc.europa.eu/en/publications/Publications/0907_TED_Influenza_AH1N1_Measuring_Influenza_Vaccine_Effectiveness_Protocol_Case_Control_Studies.pdf. Accessed: June 1, 2016
   Google Scholar
• Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, Carpenter J, Rücker G, Harbord RM, Schmid CH, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011; 343:d4002; PMID:21784880; http://dx.doi.org/10.1136/bmj.d4002
   PubMed Web of Science ®Google Scholar
• Wells GA, Sultan SA, Chen L, Khan M, Coyle D. Indirect treatment comparison [computer program]. Version 1.0. Canadian Agency for Drugs and Technologies in Health; Ottawa, 2009
   Google Scholar